Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Biomedicines
|
October 23, 2021
Airway Bacteria Quantification Using Polymerase Chain Reaction Combined with Neutrophil and Eosinophil Counts Identifies Distinct COPD Endotypes
Augusta Beech, Simon Lea, Jian Li, et al.
Biomedicines
|
August 26, 2022
Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD
Alex Mulvanny, Caroline Pattwell, Augusta Beech, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
November 27, 2025
Sputum Cytokine Repeatability in COPD
Alex Mulvanny, Augusta Beech, Jian Li, et al.
The European Respiratory Journal
|
September 11, 2025
Reduction in sputum inflammatory cells after a single dose of cepeprubart in COPD patients
Dave Singh, Thomas Southworth, Alex Mulvanny, et al.
Clinical Pharmacology and Therapeutics
|
December 24, 2025
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose Trial
Dave Singh, Chaim M Brickman, Peter Lloyd, et al.
ERJ Open Research
|
March 11, 2026
Activation of STAT3 in the COPD airway epithelium
Thomas Southworth, Charles Pilette, Alex Mulvanny, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Biomedicines
|
October 23, 2021
Airway Bacteria Quantification Using Polymerase Chain Reaction Combined with Neutrophil and Eosinophil Counts Identifies Distinct COPD Endotypes
Augusta Beech, Simon Lea, Jian Li, et al.
Biomedicines
|
August 26, 2022
Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD
Alex Mulvanny, Caroline Pattwell, Augusta Beech, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
November 27, 2025
Sputum Cytokine Repeatability in COPD
Alex Mulvanny, Augusta Beech, Jian Li, et al.
The European Respiratory Journal
|
September 11, 2025
Reduction in sputum inflammatory cells after a single dose of cepeprubart in COPD patients
Dave Singh, Thomas Southworth, Alex Mulvanny, et al.
Clinical Pharmacology and Therapeutics
|
December 24, 2025
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose Trial
Dave Singh, Chaim M Brickman, Peter Lloyd, et al.
ERJ Open Research
|
March 11, 2026
Activation of STAT3 in the COPD airway epithelium
Thomas Southworth, Charles Pilette, Alex Mulvanny, et al.
Page
of 1